Samsrita Labs reports zero revenue, writes off ₹2.09 cr receivables
The healthcare company's auditors flagged an irrecoverable debt, while accumulated losses have pushed reserves into negative territory.
— 1 earlier story on Samsrita Labs Ltd. →What's new
- Samsrita Labs posted zero revenue from operations for FY25-26.
- The company wrote off ₹2.09 cr in receivables from Mangal Savitri Bizcon, an amount its auditor flagged.
- Accumulated losses have pushed reserves to a negative ₹11.41 cr.
Why this matters
A zero-revenue company is a shell by definition, and the write-off of ₹2.09 cr from a single counterparty eats directly into the net worth of a nano-cap. The negative reserves mean the company's balance sheet is underwater, which limits its ability to raise capital or pursue the expansion it has outlined.
What we're watching
- Whether the planned pet and home-need products pivot generates any revenue in FY27.
- The company's ability to raise more capital with negative reserves.
- Any further auditor qualifications on the receivables issue.
The full read
Samsrita Labs had no revenue in FY25-26. The nano-cap, which operates in healthcare, reported a standalone loss of ₹8.69 crore and wrote off ₹2.09 crore in receivables from Mangal Savitri Bizcon, a move its auditor specifically flagged. The company raised ₹3.39 crore in equity during the year, which pushed cash to ₹1.63 crore, but the accumulated losses have now driven reserves to a negative ₹11.41 crore. Management says it plans to expand into pet and home-need products, but with zero revenue and a balance sheet in the red, the pivot is a question of survival, not strategy.
Questions answered
- How did Samsrita generate zero revenue for the full year?
- The audited results show zero revenue from operations for the year ended March 2026. The company reported losses but no top line, suggesting it has no active commercial operations.
- What was the auditor's concern about the write-off?
- The auditor flagged the ₹2.09 crore write-off of irrecoverable trade receivables from Mangal Savitri Bizcon Private Limited as an 'emphasis of matter.' This draws attention to the loss but does not constitute a qualification of the accounts.
- Why are the company's reserves negative?
- Accumulated losses over multiple periods have pushed reserves to a negative ₹11.41 crore. This is the cumulative result of the company's operating losses, including the ₹8.69 crore standalone loss in the just-completed year.
- How did the cash position improve despite the losses?
- The company's cash balance improved to ₹1.63 crore after it raised ₹3.39 crore in equity during the year. The fundraise covered the loss and added to the cash pile, but it also dilutes existing shareholders.
Story so far
All notes on SAMSRITA →- 29 May 2026 · 5:59 PM IST Samsrita Labs reports zero revenue, writes off ₹2.09 cr receivables
- 1d ago Samsrita Labs made ₹0 revenue last year. Its auditor flagged a ₹2.09 cr write-off.